Connect Biopharm Llc
Clinical trials sponsored by Connect Biopharm Llc, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental drug aims to tame severe asthma and COPD attacks Results expected Dec 2026 (estimated)
-
New shot aims to tame COPD Flare-Ups in inflammatory subtype
Disease control CompletedThis Phase 2 trial tests whether rademikibart, an injected drug, can help adults with COPD who are having a sudden flare-up and have a specific type of inflammation (type 2). The study will compare the drug to a placebo in 160 participants, looking at whether it reduces treatment…
Phase 2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
New shot could tame asthma Flare-Ups
Disease control CompletedThis Phase 2 trial tests whether adding rademikibart (a shot) to standard care can help adults and teens with asthma and type 2 inflammation avoid hospital visits or needing more steroids during an attack. About 160 participants will receive either the drug or a placebo. The main…
Phase 2 • Sponsor: Connect Biopharm LLC • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC